We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Healthcare Provider and Medical IT Vendor Offer Osteoporosis Assessment

By HospiMedica International staff writers
Posted on 27 Sep 2016
A private care provider in Sweden and a large medical Internet Technology (IT) vendor have join forces to offer preventive bone health testing for people with osteoporosis risk factors.

The screening program is intended to enable preventive measures to be taken, which can reduce or avoid the risk of fractures. More...
Half of all women in Sweden will suffer from a painful bone fracture, usually following menopause, as a result of osteoporosis, which can lead to long-term disabilities.

The OneScreen bone density analysis technology was developed by Sectra (Linköping, Sweden) and is being used by Unilabs (Stockholm, Sweden), a private care provider, to provide preventive bone health testing. The examination is carried out either together with a mammography exam at Unilabs, or separately at a Unilabs radiology clinic. The Sectra OneScreen test uses Digital X-Ray Radiogrammetry (DXR), and is based on a radiology image of the hand. Those individuals who are determined to have a high risk of osteoporosis will receive a further exam and treatment if needed. Studies have shown that the Sectra OneScreen technology can be used for effective osteoporosis care, to identify those patients at risk.

Charlotta Wikström, head of Unilabs’ radiology operation, said, “Thanks to our cooperation with Sectra, we now have the opportunity to offer a complete treatment chain for this serious disease, from initial risk assessment to follow-up and possibly further examinations and treatment.”

Related Links:
Sectra
Unilabs

Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Medical Examination & Procedure Light
Vega 80
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.